|
Resolution: standard / high Figure 1.
Proposed pathophysiological mechanisms of anti-neutrophil cytoplasmic autoantibody-associated
vasculitides. Inflammatory cytokines (IL-1β, IL-6, transforming growth factor beta (TGFβ)) released
due to bacterial or viral infections can promote skewing of a subset of functional
regulatory T cells (TRegs) towards IL-17-producing nonfunctional TRegs. These IL-17-producing cells play a key role in disease onset through their cytokine
IL-17. This cytokine induces CXC chemokine release from the target tissue that will
attract neutrophils to the site of inflammation. In addition, IL-17 stimulates the
release of IL-1β and TNFα from macrophages, which causes upregulation of the expression
of endothelial adhesion molecules and induces translocation of proteinase-3 (PR3)
and myeloperoxidase (MPO) to the neutrophil membrane (priming). Released PR3 and MPO
can be processed and presented by antigen-presenting cells (APC) to T-helper cells.
Since TRegs are converted into nonfunctional IL-17-producing cells that fail to inhibit this autoimmune
response, autoreactive T cells may undergo repeated stimulation by PR3-pulsed or MPO-pulsed
APC, resulting in a pool of effector memory T cells (TEM). In addition, PR3-stimulated T-helper cells act on B cells. The presence of IL-17
can enhance the production of anti-neutrophil cytoplasmic autoantibody (ANCA) by autoreactive
B cells. Subsequently, ANCA binds to PR3 or MPO on primed neutrophils that adhere
to endothelial cells, which enhances neutrophil activation resulting in degranulation
and release of reactive oxygen species (ROS) and proteolytic enzymes that can damage
vascular endothelial cells. Moreover, persistent activation of T-helper cells by PR3
or MPO, together with the breakdown of TReg-mediated self-tolerance mechanisms, will induce autoreactive CD4+ TEM expansion. Expanded CD4+ TEM upregulate their killer immunoglobulin-like receptor (NKG2D) and interact with their
ligand (major histocompatibility complex class-I chain-related molecule A (MICA))
on vascular endothelial cells, which in turn enhances their cytotoxic function and
kills target cells in a perforin-dependent and granzyme-dependent way, ending up in
vasculitis.
Abdulahad et al. Arthritis Research & Therapy 2011 13:236 doi:10.1186/ar3362 |